Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content

K-Pack Surshield™

Needles

Description

Browse Gallery (5)

K-Pack® Surshield™ Needles with passive sharps protection

K-Pack® Surshield™ needles are hypodermic needles equipped with a passive sharps protection intended to offer needlestick prevention solutions that support therapeutic success.

Characteristics


Sharps protection technology


K-Pack® Surshield™ needles offer an integrated passive sharps protection solution, intended to reduce the potential for needlestick injuries and the risk of spreading pathogens accidently.

Designed for subcutaneous and intramuscular injections, the protection system is ‘armed’ during needle insertion and can’t be bypassed. K-Pack® Surshield™ solutions offer simple, encapsulating protection before and after administration. 


Designed for safety

  • Simple administration routine
  • Activation of the safety mechanism directly
    associated with needle insertion
  • Reliable, permanent sharps cover eliminating user exposure 
  • Safety system is discrete with no interaction between syringe and device
  • Permanent visual indication of activation status
  • Advanced injection ergonomics
  • T-Sharp™ bevelled lancet aiming to improve patient comfort1
  • No additional assembly steps required
  • Compact design and packaging 

Regulatory and Quality Aspects

  • Regulatory status as a medical device 
  • Established validation data ready for regulatory support
  • Tamper-evident label with large color-coded area and UDI information for camera inspection
  • Proven track record of reliable supply assured by global operating company 

General specifications

​K-Pack® Surshield™ solutions are intended subcutaneous and intramuscular injections.

Specification Description
Needle PointT-SHARPTM 3-bevel lancet point
CannulasStainless steel X5CrNi 18-10
HubPolypropylene + Color Masterbatch
Conical fittingISO 80369-7 (New standard, substitutes ISO 594-1 (EN 20594-1) / ISO 594-2 (EN 1707))
Individual packagingRigid packaging with tamper-evident label
Shipping carton1500 pcs.
SterilizationEthylene Oxide
Shelf-life5 years

Global Solutions

K-Pack® Surshield™ solutions are available to drug product manufacturers globally. For more information about product availability, specifications, and applicable standards, download our data sheet or contact your Terumo representative today.

Please note that some products may not be available in all regions, check with your local TERUMO Pharmaceuticals Solutions Division contact for details. 
All brand names are trademarks or registered trademarks of TERUMO CORPORATION and their respective owners.

References

1Comparative Hypodermic Needle Sharpness Among Major Brands, 2009

Let’s Find Your Best Solution

Innovation and creativity are central to Terumo Pharmaceutical Solutions’ value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for all parenteral applications.

Contact Us

Didn't find your product?

Consult our products in our Product Index

Are you a pharmaceutical professional?

This information is intended for professionals in the pharmaceutical supply chain who are interested in primary packaging, injection components and medical devices from Terumo Pharmaceutical Solutions, for use in combination with their respective drug products (hereafter, pharmaceutical professionals). Please note that the product information contained on this website is exclusively addressed to pharmaceutical professionals. This product information is not for the general public, nor is it intended to be a substitute for professional medical advice or for the care that patients receive from their healthcare professionals. By accessing it, you (i) acknowledge having read and understood both the above message and our terms of use and, further, (ii) confirm that you do so in the capacity of a pharmaceutical professional.